Skip to main content
IMA logo

IMA

ImageneBio, Inc.
$6.02 -0.09 (-1.47%) At close · Jul 14
Market Cap
$67.90M
Shares
11,279,130

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
61/100
Short interest 3.6% of shares — P63 Days to cover 31.5 — P98 Price vs VWAP +0.2% — P55 Short-volume trend -11.6% — P16 Short interest change +2.1% — P53 Worst FTD 0.03% of shares — P65

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 404,370 395,934 +8,436 31.53
2026-06-15 395,934 445,327 -49,393 24.12
2026-05-29 445,327 445,009 +318 28.41
2026-05-15 445,009 470,339 -25,330 6.42
2026-04-30 470,339 587,281 -116,942 7.63
2026-04-15 587,281 387,034 +200,247 1.00
2026-03-31 387,034 378,159 +8,875 9.05
2026-03-13 378,159 378,568 -409 12.98
2026-02-27 378,568 369,759 +8,809 10.00
2026-02-13 369,759 386,452 -16,693 7.54
2026-01-30 386,452 384,411 +2,041 9.44
2026-01-15 384,411 397,756 -13,345 26.86
2025-12-31 397,756 385,429 +12,327 4.92
2025-12-15 385,429 376,381 +9,048 5.02
2025-11-28 376,381 375,498 +883 7.60
2025-11-14 375,498 366,955 +8,543 16.35
2025-10-31 366,955 104,875 +262,080 3.79
2025-10-15 104,875 37,409 +67,466 1.25
2025-09-30 37,409 14,934 +22,475 1.00
2025-09-15 14,934 9,780 +5,154 1.00
2025-08-29 9,780 7,964 +1,816 1.07
2025-08-15 7,964 10,003 -2,039 1.00
2025-07-31 10,003 168,630 -158,627 1.00
Showing 1–23 of 23 settlements
Key facts CIK 1835579 CUSIP 45175G207 Visit website Investor relations